Delivery Order SPE2DR25D2216-SPE2DR26F7UT7
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $2,182.08 to supply Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. The contract was awarded on December 3, 2025, with an ultimate completion date of December 4, 2025, and utilizes firm fixed pricing with no set-aside designation. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens with a ceiling value of $4,035.46. This is a firm fixed price delivery order with an ultimate completion date of December 8, 2025, performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation and represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $9,914.05 delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL doses), a diabetes medication. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order is set to be completed by November 10, 2025,...
- The Defense Logistics Agency awarded a $3,158.88 delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. This non-set-aside, firm fixed-price contract is scheduled for completion by November 6, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,744.44 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. This firm fixed price delivery order, issued on December 5, 2025, with completion targeted for December 8, 2025, represents a non-competitive award under a larger contract vehicle. The pharmaceutical products will be delivered to support federal healthcare operations, with AmerisourceBergen's place...
- The Defense Logistics Agency (DLA) awarded a $1,634.52 delivery order to AmerisourceBergen Drug Corp on May 21, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This is a firm fixed price, non-set-aside contract with a completion date of May 22, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 18, 2025, with completion targeted for August 19, 2025. This delivery order represents a firm fixed-price contract with no set-aside designation, issued under a competitive procurement process. The award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,201.66 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pen (0.5 ml), a diabetes medication. This firm fixed-price delivery order, issued on December 2, 2025, with completion targeted for December 3, 2025, was not set-aside and was competitively awarded. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,210.52 delivery order on December 23, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. This firm fixed-price delivery order, with an ultimate completion date of December 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and performance...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,180.40 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. This firm fixed-price delivery order, issued on December 4, 2025, is a non-set-aside award and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in...
- SPE2DR25D2216Indefinite Delivery Contract
- SPE2DR25D2216-SPE2DR26F7UT7Delivery Order
The Defense Logistics Agency (DLA) awarded a $8,401.84 delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by December 24, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor supporting federal military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive portfolio encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a prime vendor for federal pharmaceutical procurement, AmerisourceBergen has demonstrated capability to compete successfully for medical supply contracts ranging from small-value transactions to substantial orders exceeding $45,000. The DLA is advancing toward establishing Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, which may involve additional contractors alongside AmerisourceBergen to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 12/22/25 |